Table 3.
Distribution-based estimates for key EORTC domain scores (N = 681)
| EORTC domain | Test–retest reliabilitya | One-half standard deviationb | Standard error of measurement |
|---|---|---|---|
| EORTC QLQ-C30 Physical Functioning | 0.82 | 10.12 | 8.62 |
| EORTC QLQ-LC13 Dyspnea | 0.77 | 10.81 | 10.29 |
| EORTC QLQ-LC13 Coughing | 0.76 | 13.67 | 13.42 |
| EORTC QLQ-LC13 Pain in Chest | 0.62 | 12.06 | 14.95 |
EORTC European Organisation for Research and Treatment of Cancer, QLQ-C30 30-item core instrument, QLQ-LC13 13-item lung cancer module
aTest–retest reliability is the intraclass correlation coefficient using a two-way mixed effects regression model based on absolute agreement with screening data as the ‘test’ administration and Week 1 data as the ‘retest’ administration, using only participants who report the same value on the Global Health Status item at both administrations
b Based on Baseline scores